Picture of International Isotopes logo

INIS International Isotopes Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapHigh Flyer

Momentum

Relative Strength (%)
1m-3%
3m-13.42%
6m+46.59%
1yr-2.35%
Volume Change (%)
10d/3m-37.39%
Price vs... (%)
52w High-26.83%
50d MA-9.13%
200d MA+11.89%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital0.05%
Return on Equity0.2%
Operating Margin0.05%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202531st Dec 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of International Isotopes EPS forecast chart

Profile Summary

International Isotopes Inc. manufactures a range of radioisotope-focused products. The Company's segments include Theranostics Products, Cobalt Products, Nuclear Medicine Standards, Medical Device Products and Fluorine Products. Theranostics Products segment includes production and distribution of its generic sodium iodide I-131 drug product for the treatment of hyperthyroidism and carcinoma of the thyroid. Cobalt Products segment includes the production of bulk cobalt (cobalt-60), fabrication of cobalt capsules for radiation therapy and various industrial applications. Nuclear Medicine Standards segment consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) imaging. Fluorine Products segment is involved in the production of small-scale qualification samples of high-purity fluoride gas for various industrial applications. It is working to launch the RadVent brand of medical devices.

Directors

Last Annual
December 31st, 2024
Last Interim
December 31st, 2024
Incorporated
November 1st, 1995
Public Since
August 14th, 1997
No. of Shareholders
458
No. of Employees
41
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
us flag iconPink Sheets on Nasdaq
Shares in Issue
523,706,140

INIS Share Price Performance

Upcoming Events for INIS

Q1 2025 International Isotopes Inc Earnings Release

International Isotopes Inc Annual Shareholders Meeting

Q2 2025 International Isotopes Inc Earnings Release

Similar to INIS

Picture of Acusphere logo

Acusphere

us flag iconPink Sheets on Nasdaq

Picture of Adorbs logo

Adorbs

us flag iconPink Sheets on Nasdaq

Picture of Agentix logo

Agentix

us flag iconPink Sheets on Nasdaq

Picture of Agrios Global Holdings logo

Agrios Global Holdings

us flag iconPink Sheets on Nasdaq

Picture of Aida Pharmaceuticals logo

Aida Pharmaceuticals

us flag iconPink Sheets on Nasdaq

FAQ